| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |